TREATMENT RELATED SECONDARY MALIGNANCY side effect
What is TREATMENT RELATED SECONDARY MALIGNANCY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
TREATMENT RELATED SECONDARY MALIGNANCY and Recently Reported Side Effects
TREATMENT RELATED SECONDARY MALIGNANCY and 15 most Active Side Effect polls
TREATMENT RELATED SECONDARY MALIGNANCY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with TREATMENT RELATED SECONDARY MALIGNANCY
CARBOPLATIN METHOTREXATE MITOMYCIN NOVANTRONE PROGRAF VINCRISTINECarboplatin Side Effects Report #5500327-6
Consumer or non-health professional from UNITED KINGDOM reported CARBOPLATIN problem on Oct 09, 2007. Male patient, child 5 years of age, was diagnosed with retinoblastoma bilateral and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy, . CARBOPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, IDARUBICIN, VINCRISTINE. Patient died.
Carboplatin Side Effects Report #5443287-9
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 20, 2007. Female patient was diagnosed with retinoblastoma bilateral and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy, . CARBOPLATIN dosage: (4800 MG/M2, 8 / CYCLICAL). During the same period patient was treated with ETOPOSIDE, CYTARABINE, METHOTREXATE, VINCRISTINE. Patient died.
Vincristine Side Effects Report #5397041-7
Health Professional from UNITED STATES reported VINCRISTINE problem on July 16, 2007. Male patient, 43 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage iv and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy, . VINCRISTINE dosage: 1.4 MG/M2 PER_CYCLE IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, TOSITUMOMAB. Patient recovered.
Vincristine Side Effects Report #5397041-7
VINCRISTINE problem was reported by a Health Professional from UNITED STATES on July 16, 2007. Male patient, 43 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage iv and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy, . VINCRISTINE dosage: 1.4 MG/M2 PER_CYCLE IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, TOSITUMOMAB. Patient recovered.
Mitomycin Side Effects Report #5308842-5
Health Professional from JAPAN reported MITOMYCIN problem on Apr 18, 2007. Male patient, 68 years of age, was diagnosed with metastases to liver and was treated with MITOMYCIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy, . MITOMYCIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN. Patient died on 09/01/2004.
Methotrexate Side Effects Report #5262970-1
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Feb 21, 2007. Male patient, child 11 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CORTISONE ACETATE, DAUNORUBICIN, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE, CYTARABINE. Patient died.
Methotrexate Side Effects Report #5262971-3
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Feb 21, 2007. Female patient, 16 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, ETOPOSIDE, CISPLATIN, CARBOPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE. Patient died.
Methotrexate Side Effects Report #5262972-5
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Feb 21, 2007. Male patient, 19 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CYTARABINE, MERCAPTOPURINE, CYCLOPHOSPHAMIDE, DAUNORUBICIN. Patient died.
Methotrexate Side Effects Report #5262973-7
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Feb 21, 2007. Male patient, 15 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CORTISONE ACETATE, DAUNORUBICIN, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE, CYTARABINE. Patient died.
Methotrexate Side Effects Report #5262974-9
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Feb 21, 2007. Female patient, child 9 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. Patient died.
Methotrexate Side Effects Report #5262975-0
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Feb 21, 2007. Female patient, 15 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CORTISONE ACETATE, DAUNORUBICIN, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE, CYTARABINE. Patient died.
Methotrexate Side Effects Report #5262977-4
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Feb 21, 2007. Female patient, child 11 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, MERCAPTOPURINE. Patient died.
Methotrexate Side Effects Report #5262978-6
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Feb 21, 2007. Male patient, child 12 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CORTISONE ACETATE, DAUNORUBICIN, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE, CYTARABINE. Patient died.
Methotrexate Side Effects Report #5273332-5
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Mar 02, 2007. Male patient, 15 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, DAUNORUBICIN, CYTARABINE, CORTISON, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE. Patient died.
Methotrexate Side Effects Report #5273336-2
Consumer or non-health professional from GERMANY reported METHOTREXATE problem on Mar 02, 2007. Female patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, DAUNORUBICIN, CYTARABINE, CORTISON, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE. Patient died.
Methotrexate Side Effects Report #5273337-4
METHOTREXATE problem was reported by a Consumer or non-health professional from GERMANY on Mar 02, 2007. Male patient, child 12 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: glioma, treatment related secondary malignancy, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, DAUNORUBICIN, CYTARABINE, CORTISON, ASPARAGINASE, CYCLOPHOSPHAMIDE, MERCAPTOPURINE. Patient died.
Novantrone Side Effects Report #5661645-4
Consumer or non-health professional from ITALY reported NOVANTRONE problem on Feb 21, 2008. Male patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy, . NOVANTRONE dosage: unknown. Patient was hospitalized. Patient died on 01/01/2004.
Novantrone Side Effects Report #5661747-2
NOVANTRONE problem was reported by a Consumer or non-health professional from ITALY on Feb 21, 2008. Male patient, 27 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, cerebral haemorrhage, treatment related secondary malignancy, . NOVANTRONE dosage: 80 MG/M2, 1 IN 1 MONTHS. Patient was hospitalized. Patient died on 01/01/2006.
Prograf Side Effects Report #5533931-X
Physician from JAPAN reported PROGRAF problem on Nov 14, 2007. Female patient, child 8 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bronchitis, leiomyosarcoma, treatment related secondary malignancy, . PROGRAF dosage: unknown. During the same period patient was treated with CELLCEPT, MEDROL. Patient was hospitalized. Patient recovered.